Slingshot members are tracking this event:
Results of Phase 3 VITALITY-ALS Trial of Lead Drug Candidate Tirasemptiv Projected Q3 of 2017
Do you think this event is important to the companies below? How will it affect their stock price?
|Impact on Stocks
Slingshot Insights Explained
Nov 21, 2017
Don’t see a project related to the catalyst you care about?
Related Keywords Vitality-als, Phase 3 Study, Tirasemptiv, Als